SHE/301569 (SHE/301569)

Shenzhen Stock Exchange: SHE/301569 · CNY

CN¥19.0

+1.04 (+5.8%)· Recorded snapshot

Market cap	16B
Revenue (ttm)	946.5M
Net income (ttm)	265.8M
EPS (ttm)	CN¥0.35
Shares out	891.6M
P/E (trailing)	54.2x
Volume	38,969,896

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 946.5M
Net income (ttm): 265.8M
EPS (ttm): CN¥0.35
P/E (trailing): 54.2x
Market cap: 16B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E54.2

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC32.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/301569 indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CNY

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-12-17
Employees	709
Employees change	96
Employees growth	15.66%
Enterprise value	CNY 14.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-10-16
Fiscal year end	December
Founded	2005
Industry	Medical - Pharmaceuticals
Is primary listing	Yes
ISIN number	CNE1000080W6
Last refreshed	2026-10-28
Market cap	CNY 16B
Next earnings date	2026-12-17
Price	CNY 18.98
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	she/301569
Website	https://www.novast.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.84%
EV/Earnings	55.16x
EV/EBIT	46.06x
EV/EBITDA	41.19x
EV/FCF	48.32x
EV/Sales	15.49x
FCF / EV yield	2.07%
FCF yield	1.9%
Graham number	4.76054
Graham upside	-74.92%
P/(FCF - SBC) ratio	65.62x
P/(OCF - SBC) ratio	49.35x
P/B ratio	7.34x
P/E ratio	54.22x
P/FCF ratio	52.72x
P/OCF ratio	41.68x
P/S ratio	16.9x
Price / tangible book value	7.48x
Price/EBITDA ratio	44.95x
Sector forward P/E	20.26x
Sector P/E	37.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.62%
EBITDA margin	37.59%
Effective tax rate	13.85%
FCF margin	32.05%
Gross margin	58.21%
Operating margin	33.62%
Pretax margin	32.59%
Profit margin	28.08%
ROA (5Y)	5.26%
ROCE	13.86%
ROE (5Y)	11.34%
ROIC	32.49%
ROIC (5Y)	17.08%
SBC / revenue	6.3%
Tax / revenue	4.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	133.37%
EPS growth (Q)	32.92%
EPS growth (QoQ)	0%
FCF growth	310.21%
FCF growth (Q)	57.39%
FCF growth (QoQ)	0%
Gross profit growth	66.32%
Gross profit growth (Q)	31.86%
Net income growth	129.52%
Net income growth (Q)	36.8%
Net income growth (QoQ)	0%
OCF growth	91.01%
OCF growth (Q)	43.04%
OCF growth (QoQ)	0%
Operating income growth	267.21%
Operating income growth (Q)	70.15%
Revenue growth	35.14%
Revenue growth (Q)	11.59%
Revenue growth (QoQ)	0%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -80.4M
Depreciation and amortization	CNY 37.6M
EBIT	CNY 318.2M
EBITDA	CNY 355.8M
EPS	CNY 0.35
FCF per share	CNY 0.34
Financing cash flow	CNY -4.1M
Free cash flow	CNY 303.4M
Free cash flow minus SBC	CNY 243.7M
Gross profit	CNY 551M
Income taxes	CNY 42.7M
Investing cash flow	CNY -378.4M
Net cash flow	CNY -29.3M
Net income	CNY 265.8M
Operating cash flow minus SBC	CNY 324.1M
Operating income	CNY 318.2M
Revenue	CNY 946.5M
Stock-based compensation	CNY 59.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.95
Book value per share	CNY 2.88
Debt / equity	0
Long-term assets	CNY 675.1M
Long-term liabilities	CNY 114.7M
Net cash (debt)	CNY 1.3B
Net cash / market cap	8.36%
Net cash growth	27.36%
Net debt / EBITDA	-3.76
Net debt / equity	-0.61
Net debt / FCF	-4.41
Piotroski F-Score	5
Property, plant and equipment	CNY 593.2M
Shareholders' equity	CNY 2.2B
Tangible book value	CNY 2.1B
Tangible book value per share	CNY 2.82
Total assets	CNY 2.4B
Total cash	CNY 1.3B
Total debt	CNY 0
Total liabilities	CNY 248.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CNY 1.8B
Current liabilities	CNY 133.8M
Current ratio	13.11
Net working capital	CNY 283.4M
Quick ratio	11.29
Working capital	CNY 1.6B
Working capital turnover	0.65

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	5.8%
1W price change	-5.38%
1W total return	-5.38%
52-week high	CNY 42.15
52-week high date	2026-10-15
52-week low	CNY 16.75
52-week low date	2026-10-23
All-time high	CNY 42.15
All-time high date	2026-10-15
All-time low	CNY 16.75
All-time low date	2026-10-23
Average volume	54.1M
Change from 52-week high	-54.97%
Change from 52-week low	13.31%
Change from all-time high	-54.97%
Change from all-time low	13.31%
Change from open	11.78%
Day's gap	-5.35%
Dollar volume	CNY 739.6M
High price	CNY 19.38
Low price	CNY 16.98
Monthly RSI	0
Open price	CNY 16.98
Position in 52-week range	83.33%
Previous close	CNY 17.94
Relative volume	0.7
RSI	0
Sharpe ratio	-9.18
Sortino ratio	-8.15
Volume	39M
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	71.9M
Shares change (QoQ)	0%
Shares held by insiders	11.84%
Shares held by institutions	5.1%
Shares outstanding	891.6M

Deeper analysis on SHE/301569

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/301569 report

Is a complete SHE/301569 research report available?

No complete published report is available for she/301569 (SHE/301569) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/301569 (SHE/301569)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301569

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301569 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on SHE/301569

Frequently asked questions